Roble Belko & Company’s Lam Research LRCX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-160
Closed -$13K 341
2023
Q4
$13K Buy
+160
New +$10.9K ﹤0.01% 226
2023
Q2
Sell
-70
Closed -$4K 311
2023
Q1
$4K Hold
70
﹤0.01% 251
2022
Q4
$3K Hold
70
﹤0.01% 288
2022
Q3
$3K Hold
70
﹤0.01% 282
2022
Q2
$3K Hold
70
﹤0.01% 283
2022
Q1
$4K Hold
70
﹤0.01% 327
2021
Q4
$5K Hold
70
﹤0.01% 289
2021
Q3
$4K Hold
70
﹤0.01% 272
2021
Q2
$5K Hold
70
﹤0.01% 282
2021
Q1
$4K Hold
70
﹤0.01% 279
2020
Q4
$3K Hold
70
﹤0.01% 277
2020
Q3
$2K Buy
+70
New +$2.41K ﹤0.01% 293

Other funds holding LRCX

Roble Belko & Company's LRCX Position: Q1 2024 in Review

Roble Belko & Company sold out of Lam Research (LRCX) in Q1 2024, closing a stake of 160 shares — an estimated $13K sold.

Roble Belko & Company first reported a position in LRCX in Q3 2020 and held it in 12 quarters. The position peaked at $13K in Q4 2023. 1,730 funds tracked by Wall St. Rank hold LRCX as of Q1 2024.

  • Roble Belko & Company reported no remaining Lam Research position as of Q1 2024 after selling out during the quarter.
  • Roble Belko & Company sold 160 Lam Research shares in Q1 2024, an estimated $13K.
  • Roble Belko & Company first reported a position in Lam Research in Q3 2020 and held it in 12 quarters.
  • Roble Belko & Company's Lam Research position peaked at $13K in Q4 2023.
  • 1,730 funds tracked by Wall St. Rank held Lam Research as of Q1 2024.

Based on Roble Belko & Company's 13F filing for Q1 2024, filed 11 Apr 2024.